<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02546830</url>
  </required_header>
  <id_info>
    <org_study_id>RB14-060</org_study_id>
    <secondary_id>CHRU de Brest</secondary_id>
    <nct_id>NCT02546830</nct_id>
  </id_info>
  <brief_title>Automatic Oxygen Administration After Major Abdominal and Thoracic Surgery</brief_title>
  <acronym>FreeO2PostOp</acronym>
  <official_title>Automatic Oxygen Administration in Early and Late Postoperative Hypoxaemia Prevention After Major Abdominal and Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the use feasibility of the FreeO2 system so as to deliver
      automatically oxygen in the post anesthesia care unit in a patient population admitted for
      major abdominal and thoracic surgery.

      The investigators' hypothesis is that FreeO2 system will provide a better control of the
      oxygen saturation and reduce postoperative hypoxaemia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of time spent in the target zone of oxygen saturation</measure>
    <time_frame>3 days</time_frame>
    <description>The target zone of oxygen saturation is : SpO2 = 88-92% for COPD patient and 92-96% for non COPD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>nursing workload</measure>
    <time_frame>3 days</time_frame>
    <description>nursing workload assessed by the number of manual Oxygen flow adjustments and airway management procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in a area of severe desaturation (SpO2 &lt;85%)</measure>
    <time_frame>3 days</time_frame>
    <description>Time spent in a area of severe desaturation (SpO2 &lt;85%) evaluated by freeO2 device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in a hyperoxia area (SpO2&gt; 98%).</measure>
    <time_frame>3 days</time_frame>
    <description>Time spent in a hyperoxia area (SpO2&gt; 98%) evaluated by freeO2 device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maintaining EtCO2 in a selected area</measure>
    <time_frame>3 days</time_frame>
    <description>Maintaining EtCO2 in a selected area evaluated by freeO2 device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen consumption measured at the end of administration</measure>
    <time_frame>3 days</time_frame>
    <description>Oxygen consumption measured at the end of administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of oxygen administration during hospitalization</measure>
    <time_frame>3 days</time_frame>
    <description>Duration of oxygen administration during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of complications related to the administration of oxygen</measure>
    <time_frame>28 days max</time_frame>
    <description>Number of complications related to the administration of oxygen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of use of ventilation (invasive or noninvasive )</measure>
    <time_frame>28 days max</time_frame>
    <description>Frequency of use of ventilation (invasive or noninvasive )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>28 days max</time_frame>
    <description>Duration of hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Major Thoracic and Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>FreeO2 v2.2 active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Automatic Oxygen Administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FreeO2 v2.2 with manual oxygenation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Manual Oxygen Administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeO2 v2.2 active</intervention_name>
    <description>Automatic adjustment of oxygen through the &quot;Free O2&quot; device.
&quot;FreeO2&quot; device in mode medical data collecting(SpO2,EtCO2...).</description>
    <arm_group_label>FreeO2 v2.2 active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeO2 v2.2 with manual oxygenation</intervention_name>
    <description>Manual adjustment of oxygen without the assistance of the &quot;FreeO2&quot; device.
Only &quot;FreeO2&quot; device in mode medical data collecting(SpO2,EtCO2...).</description>
    <arm_group_label>FreeO2 v2.2 with manual oxygenation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preoperative anesthetic visit for major thoracic or abdominal surgery ( ARISCAT risk
             score ≥ 26) with general anesthesia

          -  Patient consent

        Randomization Criteria:

          -  Admission in post-anesthesia care unit after major thoracic or abdominal surgery

          -  Randomization and device establishment within a time less than one hour after the
             endotracheal intubation

          -  Availability of the prototype FreeO2

          -  Absence of criteria of gravity justifying immediately a different technique of
             ventilatory support:

               -  Disturbance of consciousness with a Glasgow Coma Score ≤ 12

               -  Serious ventricular rhythm disorders

               -  Hemodynamic instability (SBP &lt;80mmHg or recourse to vasopressors)

               -  Cardiac or respiratory arrest

               -  pH &lt; 7.35 and PaCO2 &gt; 55 mm Hg

          -  Necessity of an oxygen flow less than 15 L / min to maintain a SpO2 higher than 92%.

          -  Absence of necessity of a urgent surgery

          -  Oxygen saturation measured by Spo2 sensor

        Exclusion Criteria:

          -  BMI ≥ 35 kg/m2

          -  Obstructive sleep Apnea (with or without Mechanical therapy)

          -  Emergency Surgery for life-threatening

          -  Age &lt;18 years

          -  Pregnant women, lactating

          -  perturbed or non-cooperative patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erwan L'HER</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Brest</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erwan L'HER</last_name>
    <phone>229047937</phone>
    <phone_ext>+33</phone_ext>
    <email>erwan.lher@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Laval - Québéc</name>
      <address>
        <city>Québéc</city>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François LELLOUCHE, Pr</last_name>
    </contact>
    <investigator>
      <last_name>François LELLOUCHE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brest, University Hospital</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erwan L'HER</last_name>
      <phone>229047937</phone>
      <phone_ext>+33</phone_ext>
      <email>erwan.lher@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>erwan.lher@chu-brest.fr L'HER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel FUTIER, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel FUTIER, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir JABER, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Samir JABER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas KERFORNE, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Thomas KERFORNE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2015</study_first_submitted>
  <study_first_submitted_qc>September 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2015</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

